The story of Sildenafil presents a interesting case for investors in the pharmaceutical sector. While initially a phenomenal success, producing billions, the exclusivity expiration and the subsequent entry of off-brand https://gambling577926.blogdanica.com/41949565/viagra-and-big-pharma-a-hazardous-investment